U.S. markets closed
  • S&P Futures

    3,292.75
    +29.25 (+0.90%)
     
  • Dow Futures

    26,647.00
    +238.00 (+0.90%)
     
  • Nasdaq Futures

    11,233.00
    +100.25 (+0.90%)
     
  • Russell 2000 Futures

    1,550.60
    +11.40 (+0.74%)
     
  • Crude Oil

    37.50
    +0.11 (+0.29%)
     
  • Gold

    1,878.30
    -0.90 (-0.05%)
     
  • Silver

    23.41
    +0.05 (+0.22%)
     
  • EUR/USD

    1.1750
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    0.7810
    +0.0030 (+0.39%)
     
  • Vix

    40.28
    +6.93 (+20.78%)
     
  • GBP/USD

    1.2990
    +0.0003 (+0.02%)
     
  • USD/JPY

    104.4610
    +0.1600 (+0.15%)
     
  • BTC-USD

    13,209.09
    -8.20 (-0.06%)
     
  • CMC Crypto 200

    261.39
    -11.30 (-4.14%)
     
  • FTSE 100

    5,582.80
    -146.19 (-2.55%)
     
  • Nikkei 225

    23,261.98
    -156.53 (-0.67%)
     

Inogen to Announce First Quarter 2020 Financial Results on Tuesday, May 5, 2020

·1 min read

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2020 financial results after market close on Tuesday, May 5, 2020. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.

Individuals interested in listening to the conference call may do so by dialing (877) 858-9805 for domestic callers or (201) 689-8550 for international callers. Please reference Inogen to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at: http://investor.inogen.com/.

A replay of the call will be available beginning, May 5, 2020 at 3:30pm PT/6:30pm ET through 3:30pm PT/6:30pm ET on May 19, 2020. To access the replay, dial (877) 660-6853 or (201) 612-7415 and reference Access Code: 13672721. The webcast will also be available on Inogen's website for one year following the completion of the call.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200421005029/en/

Contacts

Investor Relations Contact:
Matt Bacso, CFA
805-879-8205

Media Contact:
Byron Myers
805-562-0503